Published by Elsevier, 1986
ISBN 10: 0444011234 ISBN 13: 9780444011237
Seller: Books From California, Simi Valley, CA, U.S.A.
Hardcover. Condition: Very Good. Minor wear on the covers, corners, and the edges. Like shelf wear. May contain some writing and or highlighting within the pages and covers.
Published by Elsevier., NY
ISBN 10: 0444011234 ISBN 13: 9780444011237
Seller: Irish Booksellers, Portland, ME, U.S.A.
Condition: Good. SHIPS FROM USA. Used books have different signs of use and do not include supplemental materials such as CDs, Dvds, Access Codes, charts or any other extra material. All used books might have various degrees of writing, highliting and wear and tear and possibly be an ex-library with the usual stickers and stamps. Dust Jackets are not guaranteed and when still present, they will have various degrees of tear and damage. All images are Stock Photos, not of the actual item. book.
Published by Plenum Press, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Good. 440 pp., hardcover, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Published by Kluwer Academic/Plenum Publishers, c1999., New York, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Research Ink, Takoma Park, MD, U.S.A.
Hardback. Condition: Very Good. viii + 271 pp. Advances in Experimental Medicine and Biology5. Rubber-stamped on front free endpaper. book.
Published by General Hospital and University of California School of Medicine, San Francisco, 1991
Seller: Carpe Diem Fine Books, ABAA, Monterey, CA, U.S.A.
First Edition
Softcover. 1st. 4to. 289pp. Tables; Charts. Turquoise wraps in very good condition (small stains and on front cover; 3 owner names; some ink notations). Papers from the symposium on antiviral chemotherapy held November 14-16, 1991 in San Francisco. Includes Table of Contents for papers; Sessions, Speakers and Faculty. Topics include Pathogenesis & Treatment; New Diagnostic Modalities for HSV Encephalitis; Drug-resistent Infections; Immunotherapy of HSV Infections; Drugs; CMV, Viral, VZV Infections; Hepatitis; Bone Marrow Transplation; HIV and other topics.
Published by Kluwer Academic / Plenum Publishers, New York., 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Tiber Books, Cockeysville, MD, U.S.A.
Hardcover. Condition: Very Good. 8vo, hardcover. No dj, as issued. Vg condition. Non-circulating ex-lib copy w/ label inside cover, exterior labels neatly removed (only markings); contents quite bright & clean, binding tight, covers glossy. viii, 271 p., illus. Proceedings of the Fifth Triennial Symposium on New Directions in Antiviral Chemotherapy, held November 13-15, 1997, in San Francisco, CA.
Published by Springer / Plenum, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: The Warm Springs Book Company, Fremont, CA, U.S.A.
First Edition
Hardcover. Condition: Fine. 1st Edition. A fine copy issued without a DJ. Former owner's name on inside of front cover; slight trace of wear to pictorial boards; 1st edition with complete number line; illustrated; 8vo., 440 pages.
Published by Springer, 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In.
Published by Springer, 2013
ISBN 10: 1475792107 ISBN 13: 9781475792102
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: new.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer US, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Published by Springer, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: booksXpress, Bayonne, NJ, U.S.A.
Soft Cover. Condition: new.
Published by Springer, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: booksXpress, Bayonne, NJ, U.S.A.
Hardcover. Condition: new.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Published by Springer US, 1999
ISBN 10: 0306461072 ISBN 13: 9780306461071
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Scientists and clinicians attending the last 'New Directions in Antiviral Therapy' conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in cubation period of active HIV infection, when the infection is clinically latent, is now un derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
Published by Springer US, 2013
ISBN 10: 1475792115 ISBN 13: 9781475792119
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.
Published by Springer, 2012
ISBN 10: 1461371503 ISBN 13: 9781461371502
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: As New. Unread book in perfect condition.
Published by Springer, 2013
ISBN 10: 1475792115 ISBN 13: 9781475792119
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 2013
ISBN 10: 1475792115 ISBN 13: 9781475792119
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.
Published by Springer, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Published by Springer, 1996
ISBN 10: 0306452944 ISBN 13: 9780306452949
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Condition: New.